First consumer products roll out in Q3 2025, creating near-term revenue potential and marking a new chapter in Jupiter's evolution Jupiter, Florida, June 09, 2025 (GLOBE NEWSWIRE) -- Jupiter Neuroscie ...

The Nugevia launch adds a new dimension to Jupiter's value proposition as a dual-path company-advancing clinical-stage therapies for CNS disorders while monetizing its platform in the booming ...

From the outside, she looked like any other teenager — bright-eyed, full of dreams, and eager to take on the world. But ...

“We are hosting the cure FA soiree on Saturday, June seventh At the Omni Hotel in Oklahoma City, and this event was born out ...

Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

The Delaware Division of Small Business announced the winners of the Spring 2025 Encouraging Development, Growth and ...

The dynamics of the Friedreich's ataxia market are anticipated to change as companies across the globe work towards the ...

While heritable human genome editing is banned in the United States, across Europe and much of the world, the technology ...

The global Oligonucleotide Synthesis Market, valued at US$8.9 billion in 2024 stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating ...

The Delaware Division of Small Business (DSB) has awarded a new round of Encouraging Development, Growth and Expansion (EDGE) ...

The Division of Small Business (DSB) announced the Spring 2025 winners of the Encouraging Development, Growth and Expansion ...